首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >Recognizing the Challenges of Oncogene Fusion Detection: A Critical Step toward Optimal Selection of Lung Cancer Patients for Targeted Therapies

【24h】

Recognizing the Challenges of Oncogene Fusion Detection: A Critical Step toward Optimal Selection of Lung Cancer Patients for Targeted Therapies

机译：认识到癌基因融合检测的挑战：肺癌患者肺癌患者的临界步骤

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2018年第10期|共3页
作者
Lynette M. Sholl;
展开▼
作者单位

Department of Pathology Brigham and Women’s Hospital and Harvard Medical School;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Recognizing the Challenges of Oncogene Fusion Detection: A Critical Step toward Optimal Selection of Lung Cancer Patients for Targeted Therapies [J] . Lynette M. Sholl Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：认识到癌基因融合检测的挑战：肺癌患者肺癌患者的临界步骤
2. hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression [J] . Michael G. Edwards, Katherine Vandervest, John Arcaroli, Biology Open . 2013,第7期

机译：hsa-miR29b（非经典Wnt信号的关键下游靶标）通过靶向MDM2表达在非小细胞肺癌细胞中发挥抗增殖作用hsa-miR29b（非经典Wnt信号的关键下游靶标）通过靶向MDM2表达在非小细胞肺癌细胞中的抗增殖作用hsa-miR29b（非经典Wnt信号的关键下游靶点）通过靶向MDM2表达在非小细胞肺癌细胞中发挥抗增殖作用
3. Detection of Juxtapleural Nodules in Lung Cancer Cases Using an Optimal Critical Point Selection Algorithm [J] . sara Saraswathi, L MaryvImmaculate Sheela Asian Pacific Journal of Cancer Prevention . 2017,第11期

机译：最佳临界点选择算法检测肺癌病例的颈胸结节
4. Radiomics Biomarkers from PET/CT Multi-modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-small Cell Lung Cancer Patients [C] . Wei Mu, Jin Qi, Hong Lu, SPIE Medical Imaging Conference . 2018

机译：PET / CT多模态融合图像的放射性标记生物标志物用于预测晚期非小细胞肺癌患者的免疫治疗反应
5. A study of medication-taking for patients with non-small cell lung cancer receiving oral targeted therapy [D] . Wickersham, Karen Ellen 2012

机译：用于接受口服靶向治疗的非小细胞肺癌患者的药物治疗
6. Quantitative detection of ALK fusion breakpoints in plasma cell-free DNA from patients with non-small cell lung cancer using PCR-based target sequencing with a tiling primer set and two-step mapping/alignment [O] . Kei Kunimasa, Kikuya Kato, Fumio Imamura, 2012

机译：使用基于平铺引物的PCR靶序列和两步作图/比对，定量检测非小细胞肺癌患者血浆无细胞DNA中ALK融合断裂点
7. 18F-FDG PET/CT for Target Volume Contouring in Lung Cancer Radiotherapy (perspective on “Comparison of Different Methods for Delineation of 18F-FDG PET–Positive Tissue for Target Volume Definition in Radiotherapy of Patients with Non–Small Cell Lung Cancer” J Nucl Med. 2005;46:1342–1348) [O] . Martin Stuschke, Christoph Pöttgen 2020

机译：18F-FDG PET / CT用于肺癌放射疗法的靶体积轮廓（视角下“不同方法对非小细胞肺癌患者放射治疗的不同方法划分为18F-FDG宠物阳性组织的诱导症”J Nucl“ MED。2005; 46：1342-1348）

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号